{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:38:00Z","timestamp":1793367480244,"version":"4.5.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41585-026-01157-4","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:24:00Z","timestamp":1780669440000},"page":"752-764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic modulation of prostate cancer disparities in men with African ancestry"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2373-7227","authenticated-orcid":false,"given":"Jenna","family":"Craddock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-7280","authenticated-orcid":false,"given":"Vanessa M.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"1157_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1157_CR2","unstructured":"Surveillance Research Program, National Cancer Institute. SEER*Explorer: an interactive website for SEER cancer statistics. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/ (2025)."},{"key":"1157_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/pros.22806","volume":"74","author":"EA Tindall","year":"2014","unstructured":"Tindall, E. A. et al. Clinical presentation of prostate cancer in Black South Africans. Prostate 74, 880\u2013891 (2014).","journal-title":"Prostate"},{"key":"1157_CR4","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/jnci\/djaf117","volume":"117","author":"SM Patrick","year":"2025","unstructured":"Patrick, S. M. et al. Prostate cancer clinicopathological presentation in South-East Africa during the 2010 decade. J. Natl Cancer Inst. 117, 2677\u20132681 (2025).","journal-title":"J. Natl Cancer Inst."},{"key":"1157_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.911101","volume":"13","author":"C Samtal","year":"2022","unstructured":"Samtal, C. et al. Review of prostate cancer genomic studies in Africa. Front. Genet. 13, 911101 (2022).","journal-title":"Front. Genet."},{"key":"1157_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001918","volume":"12","author":"SS Oh","year":"2015","unstructured":"Oh, S. S. et al. Diversity in clinical and biomedical research: a promise yet to be fulfilled. PLOS Med. 12, e1001918 (2015).","journal-title":"PLOS Med."},{"key":"1157_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/genes11121471","volume":"11","author":"DD Lewis","year":"2020","unstructured":"Lewis, D. D. & Cropp, C. D. The impact of African ancestry on prostate cancer disparities in the era of precision medicine. Genes 11, 1471 (2020).","journal-title":"Genes"},{"key":"1157_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41525-019-0111-x","volume":"5","author":"AR Bentley","year":"2020","unstructured":"Bentley, A. R., Callier, S. L. & Rotimi, C. N. Evaluating the promise of inclusion of African ancestry populations in genomics. NPJ Genom. Med. 5, 1\u20139 (2020).","journal-title":"NPJ Genom. Med."},{"key":"1157_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008641","volume":"16","author":"J Yuan","year":"2020","unstructured":"Yuan, J. et al. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry. PLoS Genet. 16, e1008641 (2020).","journal-title":"PLoS Genet."},{"key":"1157_CR10","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1038\/s41388-020-1280-x","volume":"39","author":"S Yadav","year":"2020","unstructured":"Yadav, S. et al. Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians. Oncogene 39, 4299\u20134311 (2020).","journal-title":"Oncogene"},{"key":"1157_CR11","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1016\/S2589-7500(23)00053-5","volume":"5","author":"S Sivakumar","year":"2023","unstructured":"Sivakumar, S. et al. Comprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysis. Lancet Digital Health 5, e380\u2013e389 (2023).","journal-title":"Lancet Digital Health"},{"key":"1157_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11912-024-01493-x","volume":"26","author":"E Bataba","year":"2024","unstructured":"Bataba, E. et al. Germline mutations and ancestry in prostate cancer. Curr. Oncol. Rep. 26, 175\u2013180 (2024).","journal-title":"Curr. Oncol. Rep."},{"key":"1157_CR13","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41391-025-00949-w","volume":"28","author":"EM Feng","year":"2025","unstructured":"Feng, E. M. et al. Racial variation in the advanced prostate cancer genome. Prostate Cancer Prostatic Dis. 28, 902\u2013907 (2025).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"1157_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.eururo.2023.04.006","volume":"84","author":"PXY Soh","year":"2023","unstructured":"Soh, P. X. Y. & Hayes, V. M. Common genetic variants associated with prostate cancer risk: the need for African inclusion. Eur. Urol. 84, 22\u201324 (2023).","journal-title":"Eur. Urol."},{"key":"1157_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","volume":"53","author":"DV Conti","year":"2021","unstructured":"Conti, D. V. et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat. Genet. 53, 65\u201375 (2021).","journal-title":"Nat. Genet."},{"key":"1157_CR16","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","volume":"55","author":"A Wang","year":"2023","unstructured":"Wang, A. et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat. Genet. 55, 2065\u20132074 (2023).","journal-title":"Nat. Genet."},{"key":"1157_CR17","doi-asserted-by":"publisher","first-page":"6736","DOI":"10.1158\/0008-5472.CAN-18-0254","volume":"78","author":"W Jaratlerdsiri","year":"2018","unstructured":"Jaratlerdsiri, W. et al. Whole-genome sequencing reveals elevated tumor mutational burden and initiating driver mutations in African men with treatment-na\u00efve, high-risk prostate cancer. Cancer Res. 78, 6736\u20136746 (2018).","journal-title":"Cancer Res."},{"key":"1157_CR18","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1158\/2767-9764.CRC-22-0136","volume":"2","author":"JA White","year":"2022","unstructured":"White, J. A. et al. Whole-exome sequencing of Nigerian prostate tumors from the prostate cancer transatlantic consortium (CaPTC) reveals DNA repair genes associated with African ancestry. Cancer Res. Commun. 2, 1005\u20131016 (2022).","journal-title":"Cancer Res. Commun."},{"key":"1157_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41586-022-05154-6","volume":"609","author":"W Jaratlerdsiri","year":"2022","unstructured":"Jaratlerdsiri, W. et al. African-specific molecular taxonomy of prostate cancer. Nature 609, 552\u2013559 (2022).","journal-title":"Nature"},{"key":"1157_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.6004\/jnccn.2022.7097","volume":"21","author":"K Gheybi","year":"2023","unstructured":"Gheybi, K. et al. Evaluating germline testing panels in southern African males with advanced prostate cancer. J. Natl. Compr. Canc. Netw. 21, 289\u2013296.e3 (2023).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"1157_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/pros.24471","volume":"83","author":"Y Mavura","year":"2023","unstructured":"Mavura, Y. et al. Transcriptomic profiling and genomic rearrangement landscape of Nigerian prostate cancer. Prostate 83, 395\u2013402 (2023).","journal-title":"Prostate"},{"key":"1157_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43726-w","volume":"14","author":"PXY Soh","year":"2023","unstructured":"Soh, P. X. Y. et al. Prostate cancer genetic risk and associated aggressive disease in men of African ancestry. Nat. Commun. 14, 8037 (2023).","journal-title":"Nat. Commun."},{"key":"1157_CR23","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/s41588-024-01931-3","volume":"56","author":"R Janivara","year":"2024","unstructured":"Janivara, R. et al. Heterogeneous genetic architectures of prostate cancer susceptibility in sub-Saharan Africa. Nat. Genet. 56, 2093\u20132103 (2024).","journal-title":"Nat. Genet."},{"key":"1157_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57312-9","volume":"16","author":"T Gong","year":"2025","unstructured":"Gong, T. et al. Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men. Nat. Commun. 16, 2400 (2025).","journal-title":"Nat. Commun."},{"key":"1157_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63865-6","volume":"16","author":"K Gheybi","year":"2025","unstructured":"Gheybi, K. et al. Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry. Nat. Commun. 16, 8799 (2025).","journal-title":"Nat. Commun."},{"key":"1157_CR26","first-page":"1954","volume":"10","author":"N Darwiche","year":"2020","unstructured":"Darwiche, N. Epigenetic mechanisms and the hallmarks of cancer: an intimate affair. Am. J. Cancer Res. 10, 1954\u20131978 (2020).","journal-title":"Am. J. Cancer Res."},{"key":"1157_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrg3142","volume":"13","author":"R Feil","year":"2012","unstructured":"Feil, R. & Fraga, M. F. Epigenetics and the environment: emerging patterns and implications. Nat. Rev. Genet. 13, 97\u2013109 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"1157_CR28","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1158\/1055-9965.EPI-16-0728","volume":"26","author":"R Toth","year":"2017","unstructured":"Toth, R. et al. Genetic variants in epigenetic pathways and risks of multiple cancers in the GAME-ON Consortium. Cancer Epidemiol. Biomarkers Prev. 26, 816\u2013825 (2017).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1157_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/jmedgenet-2021-107747","volume":"59","author":"R Katainen","year":"2022","unstructured":"Katainen, R. et al. Novel germline variant in the histone demethylase and transcription regulator KDM4C induces a multi-cancer phenotype. J. Med. Genet. 59, 644\u2013651 (2022).","journal-title":"J. Med. Genet."},{"key":"1157_CR30","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1002\/cam4.5443","volume":"12","author":"JK Larson","year":"2022","unstructured":"Larson, J. K. et al. KMT2A-D pathogenicity, prevalence, and variation according to a population database. Cancer Med. 12, 7234\u20137245 (2022).","journal-title":"Cancer Med."},{"key":"1157_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133462","volume":"15","author":"J Craddock","year":"2023","unstructured":"Craddock, J. et al. Alterations in the epigenetic machinery associated with prostate cancer health disparities. Cancers 15, 3462 (2023).","journal-title":"Cancers"},{"key":"1157_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev.genom.9.081307.164258","volume":"9","author":"MC Campbell","year":"2008","unstructured":"Campbell, M. C. & Tishkoff, S. A. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu. Rev. Genomics Hum. Genet. 9, 403\u2013433 (2008).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"1157_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00663-9","volume":"8","author":"A Choudhury","year":"2017","unstructured":"Choudhury, A. et al. Whole-genome sequencing for an enhanced understanding of genetic variation among South Africans. Nat. Commun. 8, 2062 (2017).","journal-title":"Nat. Commun."},{"key":"1157_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030445","volume":"9","author":"S Yegnasubramanian","year":"2019","unstructured":"Yegnasubramanian, S., Marzo, A. M. D. & Nelson, W. G. Prostate cancer epigenetics: from basic mechanisms to clinical implications. Cold Spring Harb. Perspect. Med. 9, a030445 (2019).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1157_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00639-9","volume":"8","author":"A Martin-Trujillo","year":"2017","unstructured":"Martin-Trujillo, A. et al. Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors. Nat. Commun. 8, 467 (2017).","journal-title":"Nat. Commun."},{"key":"1157_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95985-6","volume":"11","author":"HN Nguyen","year":"2021","unstructured":"Nguyen, H. N. et al. Liquid biopsy uncovers distinct patterns of DNA methylation and copy number changes in NSCLC patients with different EGFR-TKI resistant mutations. Sci. Rep. 11, 16436 (2021).","journal-title":"Sci. Rep."},{"key":"1157_CR37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41588-020-0648-8","volume":"52","author":"SG Zhao","year":"2020","unstructured":"Zhao, S. G. et al. The DNA methylation landscape of advanced prostate cancer. Nat. Genet. 52, 778\u2013789 (2020).","journal-title":"Nat. Genet."},{"key":"1157_CR38","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s43587-024-00794-x","volume":"5","author":"Z Koch","year":"2025","unstructured":"Koch, Z., Li, A., Evans, D. S., Cummings, S. & Ideker, T. Somatic mutation as an explanation for epigenetic aging. Nat. Aging 5, 709\u2013719 (2025).","journal-title":"Nat. Aging"},{"key":"1157_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02623-w","volume":"22","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1\/LATS2\/YAP1 signaling pathway in colorectal cancer. Cancer Cell Int. 22, 205 (2022).","journal-title":"Cancer Cell Int."},{"key":"1157_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2957821","volume":"2019","author":"M Tong","year":"2019","unstructured":"Tong, M. et al. Evaluation of MT family isoforms as potential biomarker for predicting progression and prognosis in gastric cancer. BioMed. Res. Int. 2019, 2957821 (2019).","journal-title":"BioMed. Res. Int."},{"key":"1157_CR41","doi-asserted-by":"publisher","first-page":"13378","DOI":"10.1038\/s41598-026-41871-y","volume":"16","author":"M Sinkala","year":"2026","unstructured":"Sinkala, M. et al. Mapping epigenetic gene variant dynamics: comparative analysis of frequency, functional impact and trait associations in African and European populations. Sci. Rep. 16, 13378 (2026).","journal-title":"Sci. Rep."},{"key":"1157_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2019.1682924","volume":"7","author":"J Musa","year":"2019","unstructured":"Musa, J. & Gr\u00fcnewald, T. G. P. Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer. Mol. Cell Oncol. 7, 1682924 (2019).","journal-title":"Mol. Cell Oncol."},{"key":"1157_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12071-2","volume":"10","author":"J Musa","year":"2019","unstructured":"Musa, J. et al. Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes. Nat. Commun. 10, 4128 (2019).","journal-title":"Nat. Commun."},{"key":"1157_CR44","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1158\/2159-8290.CD-23-0882","volume":"15","author":"TN Yamaguchi","year":"2025","unstructured":"Yamaguchi, T. N. et al. The germline and somatic origins of prostate cancer heterogeneity. Cancer Discov. 15, 988\u20131017 (2025).","journal-title":"Cancer Discov."},{"key":"1157_CR45","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ccr.2010.07.010","volume":"18","author":"SM Post","year":"2010","unstructured":"Post, S. M. et al. A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development. Cancer Cell 18, 220\u2013230 (2010).","journal-title":"Cancer Cell"},{"key":"1157_CR46","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.cell.2013.09.017","volume":"155","author":"J Zeron-Medina","year":"2013","unstructured":"Zeron-Medina, J. et al. A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection. Cell 155, 410\u2013422 (2013).","journal-title":"Cell"},{"key":"1157_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.15","volume":"5","author":"CG Stoehr","year":"2016","unstructured":"Stoehr, C. G. et al. Homozygous G\/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients. Oncogenesis 5, e205 (2016).","journal-title":"Oncogenesis"},{"key":"1157_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4047680","volume":"2019","author":"TKK Mamidi","year":"2019","unstructured":"Mamidi, T. K. K., Wu, J. & Hicks, C. Interactions between germline and somatic mutated genes in aggressive prostate cancer. Prostate Cancer 2019, 4047680 (2019).","journal-title":"Prostate Cancer"},{"key":"1157_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34994-z","volume":"13","author":"N Giannareas","year":"2022","unstructured":"Giannareas, N. et al. Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG. Nat. Commun. 13, 7320 (2022).","journal-title":"Nat. Commun."},{"key":"1157_CR50","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/2159-8290.CD-22-0027","volume":"12","author":"J Yuan","year":"2022","unstructured":"Yuan, J. et al. Prostate cancer transcriptomic regulation by the interplay of germline risk alleles, somatic mutations and 3D-genomic architecture. Cancer Discov. 12, 2838\u20132855 (2022).","journal-title":"Cancer Discov."},{"key":"1157_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/pros.10236","volume":"55","author":"K Woodson","year":"2003","unstructured":"Woodson, K., Hayes, R., Wideroff, L., Villaruz, L. & Tangrea, J. Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. Prostate 55, 199\u2013205 (2003).","journal-title":"Prostate"},{"key":"1157_CR52","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1158\/1078-0432.CCR-09-3342","volume":"16","author":"B Kwabi-Addo","year":"2010","unstructured":"Kwabi-Addo, B. et al. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin. Cancer Res. 16, 3539\u20133547 (2010).","journal-title":"Clin. Cancer Res."},{"key":"1157_CR53","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/15592294.2015.1022019","volume":"10","author":"J Devaney","year":"2015","unstructured":"Devaney, J. et al. Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men. Epigenetics 10, 319\u2013328 (2015).","journal-title":"Epigenetics"},{"key":"1157_CR54","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.21873\/anticanres.13790","volume":"39","author":"V Apprey","year":"2019","unstructured":"Apprey, V. et al. Association of genetic ancestry with DNA methylation changes in prostate cancer disparity. Anticancer. Res. 39, 5861\u20135866 (2019).","journal-title":"Anticancer. Res."},{"key":"1157_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121826","volume":"11","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Epigenome-wide association study of prostate cancer in African Americans identifies DNA methylation biomarkers for aggressive disease. Biomolecules 11, 1826 (2021).","journal-title":"Biomolecules"},{"key":"1157_CR56","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s44320-025-00153-x","volume":"21","author":"J Craddock","year":"2025","unstructured":"Craddock, J. et al. Methylation reprogramming associated with aggressive prostate cancer and ancestral disparities. Mol. Syst. Biol. 21, 1676\u20131701 (2025).","journal-title":"Mol. Syst. Biol."},{"key":"1157_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1182727","volume":"13","author":"HJ Shin","year":"2023","unstructured":"Shin, H. J., Hua, J. T. & Li, H. Recent advances in understanding DNA methylation of prostate cancer. Front. Oncol. 13, 1182727 (2023).","journal-title":"Front. Oncol."},{"key":"1157_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41585-022-00622-0","volume":"19","author":"C Arenas-Gallo","year":"2022","unstructured":"Arenas-Gallo, C. et al. Race and prostate cancer: genomic landscape. Nat. Rev. Urol. 19, 547\u2013561 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"1157_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071486","volume":"18","author":"N Nair","year":"2017","unstructured":"Nair, N., Shoaib, M. & S\u00f8rensen, C. S. Chromatin dynamics in genome stability: roles in suppressing endogenous DNA damage and facilitating DNA repair. Int. J. Mol. Sci. 18, 1486 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1157_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102409","volume":"86","author":"LF Alim","year":"2024","unstructured":"Alim, L. F., Keane, C. & Souza-Fonseca-Guimaraes, F. Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment. Curr. Opin. Immunol. 86, 102409 (2024).","journal-title":"Curr. Opin. Immunol."},{"key":"1157_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061132","volume":"8","author":"J Shi","year":"2013","unstructured":"Shi, J. et al. PMS1077 sensitizes TNF-\u03b1 induced apoptosis in human prostate cancer cells by blocking NF-\u03baB signaling pathway. PLoS ONE 8, e61132 (2013).","journal-title":"PLoS ONE"},{"key":"1157_CR62","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.274.5288.787","volume":"274","author":"DJ Van Antwerp","year":"1996","unstructured":"Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. & Verma, I. M. Suppression of TNF-\u03b1-induced apoptosis by NF-\u03baB. Science 274, 787\u2013789 (1996).","journal-title":"Science"},{"key":"1157_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92539-y","volume":"15","author":"MT Lebelo","year":"2025","unstructured":"Lebelo, M. T. et al. Associating serum testosterone levels with African ancestral prostate cancer health disparities. Sci. Rep. 15, 12013 (2025).","journal-title":"Sci. Rep."},{"key":"1157_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16112153","volume":"16","author":"M Vialat","year":"2024","unstructured":"Vialat, M. et al. Cholesterol dietary intake and tumor cell homeostasis drive early epithelial tumorigenesis: a potential modelization of early prostate tumorigenesis. Cancers 16, 2153 (2024).","journal-title":"Cancers"},{"key":"1157_CR65","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1152\/physiolgenomics.00264.2006","volume":"31","author":"K Fon Tacer","year":"2007","unstructured":"Fon Tacer, K., Kuzman, D., Seliskar, M., Pompon, D. & Rozman, D. TNF-\u03b1 interferes with lipid homeostasis and activates acute and proatherogenic processes. Physiol. Genomics 31, 216\u2013227 (2007).","journal-title":"Physiol. Genomics"},{"key":"1157_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1187279","volume":"13","author":"LK Duong","year":"2023","unstructured":"Duong, L. K. et al. Lipid metabolism in tumor immunology and immunotherapy. Front. Oncol. 13, 1187279 (2023).","journal-title":"Front. Oncol."},{"key":"1157_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/nu15234858","volume":"15","author":"M Santos-Pereira","year":"2023","unstructured":"Santos-Pereira, M. et al. Decoding the influence of obesity on prostate cancer and its transgenerational impact. Nutrients 15, 4858 (2023).","journal-title":"Nutrients"},{"key":"1157_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174293","volume":"14","author":"A Siltari","year":"2022","unstructured":"Siltari, A., Syv\u00e4l\u00e4, H., Lou, Y.-R., Gao, Y. & Murtola, T. J. Role of lipids and lipid metabolism in prostate cancer progression and the tumor\u2019s immune environment. Cancers 14, 4293 (2022).","journal-title":"Cancers"},{"key":"1157_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.23218","volume":"63","author":"AV Tuzova","year":"2024","unstructured":"Tuzova, A. V. et al. Deciphering epigenetic regulation of enhancers in high-risk prostate cancer. Genes Chromosomes Cancer 63, e23218 (2024).","journal-title":"Genes Chromosomes Cancer"},{"key":"1157_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53758-5","volume":"15","author":"UB Alt\u0131nta\u015f","year":"2024","unstructured":"Alt\u0131nta\u015f, U. B. et al. Decoding the epigenetics and chromatin loop dynamics of androgen receptor-mediated transcription. Nat. Commun. 15, 9494 (2024).","journal-title":"Nat. Commun."},{"key":"1157_CR71","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cell.2018.05.037","volume":"174","author":"DY Takeda","year":"2018","unstructured":"Takeda, D. Y. et al. A somatically acquired enhancer of the androgen receptor is a noncoding driver in advanced prostate cancer. Cell 174, 422\u2013432.e13 (2018).","journal-title":"Cell"},{"key":"1157_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17325-y","volume":"11","author":"K Walavalkar","year":"2020","unstructured":"Walavalkar, K. et al. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer. Nat. Commun. 11, 3598 (2020).","journal-title":"Nat. Commun."},{"key":"1157_CR73","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.eururo.2020.04.060","volume":"78","author":"BF Darst","year":"2020","unstructured":"Darst, B. F. et al. A germline variant at 8q24 contributes to familial clustering of prostate cancer in men of African ancestry. Eur. Urol. 78, 316\u2013320 (2020).","journal-title":"Eur. Urol."},{"key":"1157_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29235-2","volume":"13","author":"TZ Minas","year":"2022","unstructured":"Minas, T. Z. et al. Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer. Nat. Commun. 13, 1759 (2022).","journal-title":"Nat. Commun."},{"key":"1157_CR75","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2023.2180585","volume":"18","author":"CJ Creighton","year":"2023","unstructured":"Creighton, C. J. et al. Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer. Epigenetics 18, 2180585 (2023).","journal-title":"Epigenetics"},{"key":"1157_CR76","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41388-018-0488-5","volume":"38","author":"N Stylianou","year":"2019","unstructured":"Stylianou, N. et al. A molecular portrait of epithelial\u2013mesenchymal plasticity in prostate cancer associated with clinical outcome. Oncogene 38, 913\u2013934 (2019).","journal-title":"Oncogene"},{"key":"1157_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203855","volume":"13","author":"LJ Burton","year":"2018","unstructured":"Burton, L. J. et al. Association of epithelial mesenchymal transition with prostate and breast health disparities. PLoS ONE 13, e0203855 (2018).","journal-title":"PLoS ONE"},{"key":"1157_CR78","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/17501911.2025.2535938","volume":"17","author":"MS Hussain","year":"2025","unstructured":"Hussain, M. S. et al. Epigenetic alterations in prostate cancer: the role of chromatin remodeling. Epigenomics 17, 967\u2013991 (2025).","journal-title":"Epigenomics"},{"key":"1157_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02151-x","volume":"40","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. The emerging role of ISWI chromatin remodeling complexes in cancer. J. Exp. Clin. Cancer Res. 40, 346 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1157_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114725","volume":"196","author":"H Zou","year":"2022","unstructured":"Zou, H., Yang, N., Zhang, X. & Chen, H. W. ROR\u03b3 is a context-specific master regulator of cholesterol biosynthesis and an emerging therapeutic target in cancer and autoimmune diseases. Biochem. Pharmacol. 196, 114725 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"1157_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrurol.2016.221","volume":"14","author":"R Stuchbery","year":"2017","unstructured":"Stuchbery, R., McCoy, P. J., Hovens, C. M. & Corcoran, N. M. Androgen synthesis in prostate cancer: do all roads lead to Rome? Nat. Rev. Urol. 14, 49\u201358 (2017).","journal-title":"Nat. Rev. Urol."},{"key":"1157_CR82","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/s41588-024-01826-3","volume":"56","author":"SG Zhao","year":"2024","unstructured":"Zhao, S. G. et al. Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer. Nat. Genet. 56, 1689\u20131700 (2024).","journal-title":"Nat. Genet."},{"key":"1157_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42653-0","volume":"14","author":"A Bayona-Feliu","year":"2023","unstructured":"Bayona-Feliu, A. et al. The chromatin network helps prevent cancer-associated mutagenesis at transcription-replication conflicts. Nat. Commun. 14, 6890 (2023).","journal-title":"Nat. Commun."},{"key":"1157_CR84","doi-asserted-by":"publisher","unstructured":"Vandeuren, A. L. et al. The role of BAZ2-dependent chromatin remodeling in suppressing G4 DNA structures and associated genomic instability. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.12.10.627505 (2024).","DOI":"10.1101\/2024.12.10.627505"},{"key":"1157_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32472-0","volume":"13","author":"H Cui","year":"2022","unstructured":"Cui, H. et al. The SWI\/SNF chromatin remodeling factor DPF3 regulates metastasis of ccRCC by modulating TGF-\u03b2 signaling. Nat. Commun. 13, 4680 (2022).","journal-title":"Nat. Commun."},{"key":"1157_CR86","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bbrc.2019.04.170","volume":"514","author":"W Lin","year":"2019","unstructured":"Lin, W. et al. Downregulation of DPF3 promotes the proliferation and motility of breast cancer cells through activating JAK2\/STAT3 signaling. Biochem. Biophys. Res. Commun. 514, 639\u2013644 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1157_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000684","volume":"5","author":"Q Li","year":"2009","unstructured":"Li, Q. et al. The elongator complex interacts with PCNA and modulates transcriptional silencing and sensitivity to DNA damage agents. PLoS Genet. 5, e1000684 (2009).","journal-title":"PLoS Genet."},{"key":"1157_CR88","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abb9820","volume":"13","author":"P Cruz-Gordillo","year":"2020","unstructured":"Cruz-Gordillo, P., Honeywell, M. E., Harper, N. W., Leete, T. & Lee, M. J. ELP-dependent expression of MCL1 promotes resistance to EGFR inhibition in triple-negative breast cancer cells. Sci. Signal. 13, eabb9820 (2020).","journal-title":"Sci. Signal."},{"key":"1157_CR89","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1038\/bjc.2013.200","volume":"108","author":"M Khursheed","year":"2013","unstructured":"Khursheed, M. et al. ARID1B, a member of the human SWI\/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines. Br. J. Cancer 108, 2056\u20132062 (2013).","journal-title":"Br. J. Cancer"},{"key":"1157_CR90","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh4435","volume":"10","author":"A D\u2019Ambrosio","year":"2024","unstructured":"D\u2019Ambrosio, A. et al. Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations. Sci. Adv. 10, eadh4435 (2024).","journal-title":"Sci. Adv."},{"key":"1157_CR91","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.1093\/nar\/gkae233","volume":"52","author":"A Bakr","year":"2024","unstructured":"Bakr, A. et al. ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response. Nucleic Acids Res. 52, 5698\u20135719 (2024).","journal-title":"Nucleic Acids Res."},{"key":"1157_CR92","doi-asserted-by":"publisher","DOI":"10.1289\/EHP353","volume":"125","author":"FW Gaspar","year":"2017","unstructured":"Gaspar, F. W. et al. Levels and determinants of DDT and DDE exposure in the VHEMBE cohort. Environ. Health Perspect. 125, 077006 (2017).","journal-title":"Environ. Health Perspect."},{"key":"1157_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/toxics6040065","volume":"6","author":"BO Anyanwu","year":"2018","unstructured":"Anyanwu, B. O., Ezejiofor, A. N., Igweze, Z. N. & Orisakwe, O. E. Heavy metal mixture exposure and effects in developing nations: an update. Toxics 6, 65 (2018).","journal-title":"Toxics"},{"key":"1157_CR94","volume":"6","author":"T Gutu Sakketa","year":"2023","unstructured":"Gutu Sakketa, T. Urbanisation and rural development in sub-Saharan Africa: a review of pathways and impacts. Res. Glob. 6, 100133 (2023).","journal-title":"Res. Glob."},{"key":"1157_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15173","volume":"9","author":"EG Anaduaka","year":"2023","unstructured":"Anaduaka, E. G. et al. Widespread use of toxic agrochemicals and pesticides for agricultural products storage in Africa and developing countries: possible panacea for ecotoxicology and health implications. Heliyon 9, e15173 (2023).","journal-title":"Heliyon"},{"key":"1157_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35572","volume":"131","author":"SJC Soerensen","year":"2025","unstructured":"Soerensen, S. J. C. et al. Pesticides and prostate cancer incidence and mortality: an environment-wide association study. Cancer 131, e35572 (2025).","journal-title":"Cancer"},{"key":"1157_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-97682-0","volume":"15","author":"D Coradduzza","year":"2025","unstructured":"Coradduzza, D. et al. Associations between plasma and urinary heavy metal concentrations and the risk of prostate cancer. Sci. Rep. 15, 14274 (2025).","journal-title":"Sci. Rep."},{"key":"1157_CR98","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2217\/epi.09.45","volume":"2","author":"JF Reichard","year":"2010","unstructured":"Reichard, J. F. & Puga, A. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics 2, 87\u2013104 (2010).","journal-title":"Epigenomics"},{"key":"1157_CR99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1289\/ehp.1002114","volume":"119","author":"X Ren","year":"2011","unstructured":"Ren, X. et al. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ. Health Perspect. 119, 11\u201319 (2011).","journal-title":"Environ. Health Perspect."},{"key":"1157_CR100","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.taap.2015.04.011","volume":"286","author":"KE Pelch","year":"2015","unstructured":"Pelch, K. E., Tokar, E. J., Merrick, B. A. & Waalkes, M. P. Differential DNA methylation profile of key genes in malignant prostate epithelial cells transformed by inorganic arsenic or cadmium. Toxicol. Appl. Pharmacol. 286, 159\u2013167 (2015).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"1157_CR101","doi-asserted-by":"crossref","DOI":"10.1093\/eep\/dvab013","volume":"7","author":"A Vaiserman","year":"2021","unstructured":"Vaiserman, A. & Lushchak, O. DNA methylation changes induced by prenatal toxic metal exposure: an overview of epidemiological evidence. Environ. Epigenet. 7, dvab007 (2021).","journal-title":"Environ. Epigenet."},{"key":"1157_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01536-3","volume":"15","author":"A Stepanyan","year":"2023","unstructured":"Stepanyan, A. et al. Long-term environmental metal exposure is associated with hypomethylation of CpG sites in NFKB1 and other genes related to oncogenesis. Clin. Epigenet. 15, 126 (2023).","journal-title":"Clin. Epigenet."},{"key":"1157_CR103","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","volume":"2","author":"Y Xia","year":"2014","unstructured":"Xia, Y., Shen, S. & Verma, I. M. NF-\u03baB, an active player in human cancers. Cancer Immunol. Res. 2, 823\u2013830 (2014).","journal-title":"Cancer Immunol. Res."},{"key":"1157_CR104","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1038\/onc.2014.422","volume":"34","author":"DP Labb\u00e9","year":"2015","unstructured":"Labb\u00e9, D. P. et al. Role of diet in prostate cancer: the epigenetic link. Oncogene 34, 4683\u20134691 (2015).","journal-title":"Oncogene"},{"key":"1157_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canep.2018.01.003","volume":"53","author":"MC DeRouen","year":"2018","unstructured":"DeRouen, M. C. et al. Impact of individual and neighborhood factors on disparities in prostate cancer survival. Cancer Epidemiol. 53, 1\u201311 (2018).","journal-title":"Cancer Epidemiol."},{"key":"1157_CR106","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1016\/j.clgc.2019.06.006","volume":"17","author":"SA Weprin","year":"2019","unstructured":"Weprin, S. A. et al. Association of low socioeconomic status with adverse prostate cancer pathology among African American men who underwent radical prostatectomy. Clin. Genitourin. Cancer 17, e1054\u2013e1059 (2019).","journal-title":"Clin. Genitourin. Cancer"},{"key":"1157_CR107","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10552-019-01159-1","volume":"30","author":"AG Cuevas","year":"2019","unstructured":"Cuevas, A. G. et al. Placing prostate cancer disparities within a psychosocial context: challenges and opportunities for future research. Cancer Causes Control 30, 443\u2013456 (2019).","journal-title":"Cancer Causes Control"},{"key":"1157_CR108","unstructured":"Woods-Burnham, L. et al. Psychosocial stress, glucocorticoid signaling, and prostate cancer health disparities in African American men. Cancer Health Disparities https:\/\/companyofscientists.com\/index.php\/chd\/article\/view\/169\/188 (2020)."},{"key":"1157_CR109","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2013.12.003","volume":"264","author":"AS Zannas","year":"2014","unstructured":"Zannas, A. S. & West, A. E. Epigenetics and the regulation of stress vulnerability and resilience. Neuroscience 264, 157\u2013170 (2014).","journal-title":"Neuroscience"},{"key":"1157_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0828-5","volume":"16","author":"AS Zannas","year":"2015","unstructured":"Zannas, A. S. et al. Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling. Genome Biol. 16, 266 (2015).","journal-title":"Genome Biol."},{"key":"1157_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3635-4","volume":"17","author":"IE Flores","year":"2017","unstructured":"Flores, I. E. et al. Stress alters the expression of cancer-related genes in the prostate. BMC Cancer 17, 621 (2017).","journal-title":"BMC Cancer"},{"key":"1157_CR112","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40572-020-00269-2","volume":"7","author":"JC Nwanaji-Enwerem","year":"2020","unstructured":"Nwanaji-Enwerem, J. C. & Colicino, E. DNA methylation-based biomarkers of environmental exposures for human population studies. Curr. Environ. Health Rep. 7, 121\u2013128 (2020).","journal-title":"Curr. Environ. Health Rep."},{"key":"1157_CR113","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-publhealth-040617-014629","volume":"39","author":"EM Martin","year":"2018","unstructured":"Martin, E. M. & Fry, R. C. Environmental influences on the epigenome: exposure-associated DNA methylation in human populations. Annu. Rev. Public Health 39, 309\u2013333 (2018).","journal-title":"Annu. Rev. Public Health"},{"key":"1157_CR114","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41370-019-0183-9","volume":"31","author":"E Colicino","year":"2021","unstructured":"Colicino, E. et al. Blood DNA methylation biomarkers of cumulative lead exposure in adults. J. Expo. Sci. Environ. Epidemiol. 31, 108\u2013116 (2021).","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"1157_CR115","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/17501911.2025.2500907","volume":"17","author":"P Christofidou","year":"2025","unstructured":"Christofidou, P. & Bell, C. G. The predictive power of profiling the DNA methylome in human health and disease. Epigenomics 17, 599\u2013610 (2025).","journal-title":"Epigenomics"},{"key":"1157_CR116","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","unstructured":"Cancer Genome Atlas Research Network The molecular taxonomy of primary prostate cancer. Cell 163, 1011\u20131025 (2015).","journal-title":"Cell"},{"key":"1157_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002639","volume":"8","author":"BE Stranger","year":"2012","unstructured":"Stranger, B. E. et al. Patterns of cis regulatory variation in diverse human populations. PLoS Genet. 8, e1002639 (2012).","journal-title":"PLoS Genet."},{"key":"1157_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004549","volume":"10","author":"AR Martin","year":"2014","unstructured":"Martin, A. R. et al. Transcriptome sequencing from diverse human populations reveals differentiated regulatory architecture. PLoS Genet. 10, e1004549 (2014).","journal-title":"PLoS Genet."},{"key":"1157_CR119","doi-asserted-by":"publisher","first-page":"144","DOI":"10.22465\/juo.244800340017","volume":"22","author":"VM Hayes","year":"2024","unstructured":"Hayes, V. M. et al. Health equity research outcomes and improvement consortium prostate cancer health precision Africa1K: closing the health equity gap through rural community inclusion. J. Urol. Oncol. 22, 144\u2013149 (2024).","journal-title":"J. Urol. Oncol."},{"key":"1157_CR120","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1158\/0008-5472.CAN-05-3408","volume":"66","author":"SA Belinsky","year":"2006","unstructured":"Belinsky, S. A. et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res. 66, 3338\u20133344 (2006).","journal-title":"Cancer Res."},{"key":"1157_CR121","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1093\/carcin\/bgm206","volume":"28","author":"Y Kanai","year":"2007","unstructured":"Kanai, Y. & Hirohashi, S. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28, 2434\u20132442 (2007).","journal-title":"Carcinogenesis"},{"key":"1157_CR122","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou, W., Laird, P. W. & Shen, H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 45, e22 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1157_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s43682-022-00015-9","volume":"2","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z., Zeng, C. & Zhang, W. Characterization of the Illumina EPIC array for optimal applications in epigenetic research targeting diverse human populations. Epigenet. Commun. 2, 7 (2022).","journal-title":"Epigenet. Commun."},{"key":"1157_CR124","first-page":"45","volume":"76","author":"R Ross","year":"1986","unstructured":"Ross, R. et al. Serum testosterone levels in healthy young Black and White men. J. Natl Cancer Inst. 76, 45\u201348 (1986).","journal-title":"J. Natl Cancer Inst."},{"key":"1157_CR125","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/0039-128X(92)90032-5","volume":"57","author":"L Ellis","year":"1992","unstructured":"Ellis, L. & Nyborg, H. Racial\/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids 57, 72\u201375 (1992).","journal-title":"Steroids"},{"key":"1157_CR126","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40615-014-0049-8","volume":"2","author":"H Hu","year":"2015","unstructured":"Hu, H., Odedina, F. T., Reams, R. R., Lissaker, C. T. K. & Xu, X. Racial differences in age-related variations of testosterone levels among US males: potential implications for prostate cancer and personalized medication. J. Racial Ethn. Health Disparities 2, 69\u201376 (2015).","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"1157_CR127","doi-asserted-by":"publisher","first-page":"42575","DOI":"10.18632\/oncotarget.6471","volume":"6","author":"VK Dhiman","year":"2015","unstructured":"Dhiman, V. K., Attwood, K., Campbell, M. J. & Smiraglia, D. J. Hormone stimulation of androgen receptor mediates dynamic changes in DNA methylation patterns at regulatory elements. Oncotarget 6, 42575\u201342589 (2015).","journal-title":"Oncotarget"},{"key":"1157_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s12863-018-0703-y","volume":"19","author":"R Arathimos","year":"2018","unstructured":"Arathimos, R., Sharp, G. C., Granell, R., Tilling, K. & Relton, C. L. Associations of sex hormone-binding globulin and testosterone with genome-wide DNA methylation. BMC Genet. 19, 113 (2018).","journal-title":"BMC Genet."},{"key":"1157_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01119-0","volume":"13","author":"EB Ylitalo","year":"2021","unstructured":"Ylitalo, E. B. et al. A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer. Clin. Epigenet. 13, 133 (2021).","journal-title":"Clin. Epigenet."},{"key":"1157_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0161-6","volume":"7","author":"MS Geybels","year":"2015","unstructured":"Geybels, M. S. et al. Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors. Clin. Epigenet. 7, 128 (2015).","journal-title":"Clin. Epigenet."},{"key":"1157_CR131","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1158\/2159-8290.CD-12-0041","volume":"2","author":"ST B\u00f6rno","year":"2012","unstructured":"B\u00f6rno, S. T. et al. Genome-wide DNA methylation events in TMPRSS2\u2013ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation. Cancer Discov. 2, 1024\u20131035 (2012).","journal-title":"Cancer Discov."},{"key":"1157_CR132","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/aje\/kwx235","volume":"186","author":"CK Zhou","year":"2017","unstructured":"Zhou, C. K. et al. TMPRSS2:ERG gene fusions in prostate cancer of West African men and a meta-analysis of racial differences. Am. J. Epidemiol. 186, 1352\u20131361 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"1157_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1521204","volume":"15","author":"FC Bugoye","year":"2025","unstructured":"Bugoye, F. C. et al. Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management. Front. Oncol. 15, 1521204 (2025).","journal-title":"Front. Oncol."},{"key":"1157_CR134","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/pros.23823","volume":"79","author":"J Blackburn","year":"2019","unstructured":"Blackburn, J. et al. TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: a focus on Africa. Prostate 79, 1191\u20131196 (2019).","journal-title":"Prostate"},{"key":"1157_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01096-w","volume":"14","author":"T Gong","year":"2022","unstructured":"Gong, T. et al. Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers. Genome Med. 14, 100 (2022).","journal-title":"Genome Med."},{"key":"1157_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71285-7","volume":"14","author":"W Niu","year":"2024","unstructured":"Niu, W., Li, G., Zhang, T. & Ma, L. Prostate cancer subtyping and differential methylation analysis based on the ETS family of transcription factors fusion genes. Sci. Rep. 14, 20782 (2024).","journal-title":"Sci. Rep."},{"key":"1157_CR137","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1158\/0008-5472.CAN-22-2236","volume":"83","author":"J Gallon","year":"2023","unstructured":"Gallon, J. et al. DNA methylation landscapes of prostate cancer brain metastasis are shaped by early driver genetic alterations. Cancer Res. 83, 1203\u20131213 (2023).","journal-title":"Cancer Res."},{"key":"1157_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152481","volume":"17","author":"J Jiang","year":"2025","unstructured":"Jiang, J. et al. Scaling for African inclusion in high-throughput whole cancer genome bioinformatic workflows. Cancers 17, 2481 (2025).","journal-title":"Cancers"}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01157-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:01:43Z","timestamp":1793365303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01157-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":138,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1157"],"URL":"https:\/\/doi.org\/10.1038\/s41585-026-01157-4","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"7 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}